People: Catalyst Pharmaceuticals Inc (CPRX.O)

CPRX.O on Consolidated Issue listed on NASDAQ Capital Market

4.78USD
30 Jul 2015
Change (% chg)

$-0.14 (-2.89%)
Prev Close
$4.92
Open
$4.92
Day's High
$4.92
Day's Low
$4.71
Volume
153,489
Avg. Vol
982,408
52-wk High
$5.80
52-wk Low
$2.15

Search Stocks

Mosquera, Bernardino 

Dr. Bernardino Mosquera, M.D. has been appointed as Vice President - Clinical Operations of Catalyst Pharmaceutical Partners, Inc. effective March 5, 2013. For the last three years, Dr. Mosquera managed his own clinical research consulting company. As an independent consultant, Dr. Mosquera was involved in trials for Alzheimer’s, Parkinson’s, and stroke medications for a multinational pharmaceutical company and several biotech companies. Prior to his time as an independent consultant, for approximately five years Dr. Mosquera worked first with Amgen and later as a dedicated contractor for Amgen on a number of Phase 3 trials in the oncology area. Prior to his time with Amgen, Dr. Mosquera worked with Kos Pharmaceuticals where he was involved in all aspects of clinical trial management for two Phase 3 trials, where he was responsible for CRO selection, site selection, vendor management, creation of study documents, IRB submissions, trial management, and CRA management. Dr. Mosquera received his medical degree from the Central University of Venezuela, School of Medicine. He also holds a master’s degree in public health from the University of South Florida.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Patrick McEnany

1,470,890

Alicia Grande

714,113

Steven Miller

863,334

David Muth

--

M. Douglas Winship

258,429

David Caponera

--
As Of  30 Dec 2014
Search Stocks